Excessive Short-acting Beta-agonists Prescriptions in COPD Treated with Triple Inhaler Therapy: A Possible Marker of Frequent Exacerbations. A Retrospective Cohort Study
A significant number of subjects were prescribed SABA despite SITT therapy. A relationship between SABA packages and the number of exacerbations, assessed by OC/antibiotic prescriptions, was observed. Excessive SABA use or prescription may indicate frequent exacerbations in patients with COPD despite receiving maximal inhaled therapy.
Authors
- E. Petrucci
- Maurizio Di Tomassi
- Sara Croce
- Claudio Micheletto (ORCID: https://orcid.org/0000-0002-1138-3882)
- Alberto Cresti (ORCID: https://orcid.org/0000-0003-2328-8943)
- Valerio Alonzi
- Leonardo Gianluca Lacerenza (ORCID: https://orcid.org/0000-0002-9315-1654)
- Andrea Serafini (ORCID: https://orcid.org/0000-0003-2686-4731)
- Marco Scalese
- P. Baratta
- Alberto Ricci
- Antonio Perrella
- Bruno Sposato
Institutions
- University of Verona (IT)
- Istituto di Fisiologia Clinica (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Ospedale Misericordia - Grosseto (IT)
- National Research Council (IT)
- Azienda Usl Toscana Centro (IT)
Publication Details
- Journal
- Thoracic research and practice
- Published
- 2026-01-15
- DOI
- https://doi.org/10.4274/thoracrespract.2025.2025-6-1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00